Literature DB >> 10411921

In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells.

K J Flynn1, J M Riberdy, J P Christensen, J D Altman, P C Doherty.   

Abstract

The virus-specific CD8(+) T cell response has been analyzed through the development, effector, and recovery phases of primary and secondary influenza pneumonia. Apparently, most, if not all, memory T cells expressing clonotypic receptors that bind a tetrameric complex of influenza nucleoprotein (NP)(366-374) peptide+H-2D(b) (NPP) are induced to divide during the course of this localized respiratory infection. The replicative phase of the recall response ends about the time that virus can no longer be recovered from the lung, whereas some primary CD8(+)NPP(+) T cells may proliferate for a few more days. The greatly expanded population of CD8(+)NPP(+) memory T cells in the lymphoid tissue of secondarily challenged mice declines progressively in mean prevalence over the ensuing 100 days, despite the fact that at least some of these lymphocytes continue to cycle. The recall of cell-mediated immunity thus is characterized by massive proliferation of the antigen-specific CD8(+) set, whereas the extent of lymphocyte turnover in the absence of cognate peptide is variable, at a low level, and can be influenced by intercurrent infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411921      PMCID: PMC17562          DOI: 10.1073/pnas.96.15.8597

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Cytotoxic T-cell memory without antigen.

Authors:  L L Lau; B D Jamieson; T Somasundaram; R Ahmed
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

2.  Future influenza vaccines and the use of genetic recombinants.

Authors:  E D Kilbourne
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

Review 3.  Control of lymphocyte homing.

Authors:  L J Picker
Journal:  Curr Opin Immunol       Date:  1994-06       Impact factor: 7.486

4.  Development and function of cytotoxic T lymphocytes (CTL). I. In vivo maturation of CTL precursors in the absence of detectable proliferation results as a normal consequence of alloimmunization.

Authors:  A K Kimura; H Wigzell
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

5.  Does clonal selection occur among T cells?

Authors:  N A Mitchison; S Pettersson
Journal:  Ann Immunol (Paris)       Date:  1983 Jul-Aug

6.  Frequencies and regulation of trinitrophenyl-specific cytotoxic T precursor cells: immunization results in release from suppression.

Authors:  U Hamann; K Eichmann; P H Krammer
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

7.  Consequences of cyclophosphamide treatment in murine lymphocytic choriomeningitis: evidence for cytotoxic T cell replication in vivo.

Authors:  J E Allan; P C Doherty
Journal:  Scand J Immunol       Date:  1985-10       Impact factor: 3.487

8.  Virus-specific CD8+ T-cell memory determined by clonal burst size.

Authors:  S Hou; L Hyland; K W Ryan; A Portner; P C Doherty
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

9.  Temporal loss of the activated L-selectin-low phenotype for virus-specific CD8+ memory T cells.

Authors:  R A Tripp; S Hou; P C Doherty
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

10.  Turnover of naive- and memory-phenotype T cells.

Authors:  D F Tough; J Sprent
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  47 in total

1.  The arrival of HLA class II tetramers.

Authors:  A J McMichael; A Kelleher
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.

Authors:  G T Belz; W Xie; J D Altman; P C Doherty
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Analysis of virus-specific CD4(+) t cells during long-term gammaherpesvirus infection.

Authors:  E Flaño; D L Woodland; M A Blackman; P C Doherty
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Measuring the diaspora for virus-specific CD8+ T cells.

Authors:  D R Marshall; S J Turner; G T Belz; S Wingo; S Andreansky; M Y Sangster; J M Riberdy; T Liu; M Tan; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

5.  Diminished primary and secondary influenza virus-specific CD8(+) T-cell responses in CD4-depleted Ig(-/-) mice.

Authors:  J M Riberdy; J P Christensen; K Branum; P C Doherty
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory.

Authors:  J P Christensen; P C Doherty; K C Branum; J M Riberdy
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Turning immunological memory into amnesia by depletion of dividing T cells.

Authors:  Bertrand Bellier; Véronique Thomas-Vaslin; Marie-Françoise Saron; David Klatzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-21       Impact factor: 11.205

8.  Quantitative analysis of long-term virus-specific CD8+-T-cell memory in mice challenged with unrelated pathogens.

Authors:  Haiyan Liu; Samita Andreansky; Gabriela Diaz; Stephen J Turner; Dominik Wodarz; Peter C Doherty
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope.

Authors:  Katherine Kedzierska; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

10.  Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion.

Authors:  Nicole L La Gruta; William T Rothwell; Tania Cukalac; Natasha G Swan; Sophie A Valkenburg; Katherine Kedzierska; Paul G Thomas; Peter C Doherty; Stephen J Turner
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.